Skip to content
Head to head

Alamar Biosciences vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: ALMR · ABT

Updated moments ago

1-year performance, rebased to 100

ALMR +20.4%ABT +7.2%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories has the highest Quant Rating (22); Abbott Laboratories pays the highest dividend yield; Abbott Laboratories earns the most per share.
ALMRABT
Snapshot
SectorMedical DevicesMedical Devices
Last price26.48103.00
Change today-7.67%-0.84%
1-year return---15.4%
Market cap$1.84B$178.39B
52-week range18.85 – 39.6180.89 – 126.70
Valuation
P/E (TTM)-23.0138.29
P/E percentile, own 5-yr range97th99th
P/B6.063.50
Dividend yield0.00%2.41%
Profitability & growth
EPS (TTM)-0.543.72
Net profit (TTM)$-37.52M$6.44B
Revenue (TTM)$114.05M$48.23B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+68.5%+14.5%
Gross margin59.3%56.9%
Operating margin-42.1%13.8%
Net margin-48.2%9.7%
Free cash flow (TTM)$-69.05M$6.76B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership65.1%81.2%
Insider activity (12mo)23 buy / 24 sell36 buy / 12 sell
Short interest (% of float)3.2%1.1%
Analyst consensus50% buy / 50% hold (2)93% buy / 7% hold (15)
Analyst price target$36 (+36%)$122 (+18%)
StockVane view
StockVane Quant RatingC (0)D (22)
Company
Employees222115,000
Founded20181900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.